Net sales rose 54% year-over-year to 4,981 KSEK, driven by the Spirotronic AB acquisition, but operating losses widened to -2,861 KSEK. Strong cash position and new share issues support ongoing acquisition strategy and expansion in the healthcare sector.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.